Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Cash & Equivalents: 2018-2024

Historic Cash & Equivalents for Verastem (VSTM) over the last 6 years, with Dec 2024 value amounting to $88.8 million.

  • Verastem's Cash & Equivalents rose 21.68% to $137.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.7 million, marking a year-over-year increase of 21.68%. This contributed to the annual value of $88.8 million for FY2024, which is N/A change from last year.
  • As of FY2024, Verastem's Cash & Equivalents stood at $88.8 million, which was up 12.32% from $79.1 million recorded in FY2022.
  • In the past 5 years, Verastem's Cash & Equivalents ranged from a high of $88.8 million in FY2024 and a low of $67.8 million during FY2020.
  • For the 2-year period, Verastem's Cash & Equivalents averaged around $83.9 million, with its median value being $83.9 million (2022).
  • Data for Verastem's Cash & Equivalents shows a peak YoY spiked of 55.77% (in 2020) over the last 5 years.
  • Verastem's Cash & Equivalents (Yearly) stood at $67.8 million in 2020, then rose by 10.34% to $74.8 million in 2021, then grew by 5.73% to $79.1 million in 2022, then reached $88.8 million in 2024.